Hypertension, which is characterized by multiple alterations in the structure and function of the cell membrane, is often associated with important metabolic abnormalities including those concerning lipid metabolism. Dyslipidemia accompanying essential hypertension consists of elevated plasma triglycerides, low HDL cholesterol, and increased levels of atherogenic LDL cholesterol particles. The altered membrane microviscosity seen in hypertensive subjects reflects the changes of membrane lipid composition resulting from intensive exchange between circulating and membrane lipids, as well as from abnormal cellular lipid synthesis and metabolism. The changes of membrane microviscosity are known to modulate the activity of proteins involved in ion transport, signal transduction, cell Ca 2؉ handling, intracellular pH regulation, etc. Alterations in plasma or membrane lipids are indeed closely associated with ion transport abnormalities as well as with impaired control of cytosolic Ca 2؉ T here is no doubt that essential hypertension is associated with multiple membrane alterations, including changes in membrane microviscosity, receptor function, signal transduction, ion transport, calcium mobilization, intracellular pH regulation, and so on. Lipids, as an integral part of the cell membrane, play a decisive role in the modulation of the membrane properties mentioned. Specific lipid-lipid and lipid-protein interactions result in a highly dynamic but precisely controlled architecture of membrane components. Major regulators of membrane architecture are membrane potential, intracellular Ca 2ϩ and pH, lipid composition, cell-to-cell contact, and membrane coupling with the cytoskeleton or extracellular matrix. Intermolecular associations in the membrane and at the membrane-cytoskeleton interface are further selectively controlled by specific phosphorylation and dephosphorylation cascades involving both proteins and lipids. This is regulated by the extracellular matrix as well as by the binding of growth factors and hormones to their specific receptors.
T here is no doubt that essential hypertension is associated with multiple membrane alterations, including changes in membrane microviscosity, receptor function, signal transduction, ion transport, calcium mobilization, intracellular pH regulation, and so on. Lipids, as an integral part of the cell membrane, play a decisive role in the modulation of the membrane properties mentioned. Specific lipid-lipid and lipid-protein interactions result in a highly dynamic but precisely controlled architecture of membrane components. Major regulators of membrane architecture are membrane potential, intracellular Ca 2ϩ and pH, lipid composition, cell-to-cell contact, and membrane coupling with the cytoskeleton or extracellular matrix. Intermolecular associations in the membrane and at the membrane-cytoskeleton interface are further selectively controlled by specific phosphorylation and dephosphorylation cascades involving both proteins and lipids. This is regulated by the extracellular matrix as well as by the binding of growth factors and hormones to their specific receptors. 1, 2 The aim of this review is to outline some interrelationships between abnormal lipid metabolism and altered membrane structure or function in human and experimental hypertension, and to evaluate whether abnormal lipid metabolism, which is responsible for a great part of membrane abnormalities found in hypertension, might be an integral part of its pathogenetic mechanisms.
BLOOD PRESSURE
Multiple metabolic abnormalities often accompany essential hypertension. Decreased high-density lipoproteins (HDL) together with increased plasma levels of low-density (LDL) and very low-density lipoproteins (VLDL), as well as hypertriglyceridemia, hypercholesterolemia, and insulin resistance, were found in many hypertensive patients. 3, 4 There is increasing evidence for a genetic basis for the association of hypertension with insulin resistance and dyslipidemia. The genetic locus associated with dyslipidemia accompanying hypertension or diabetes seems to be closely linked to the LDL receptor and insulin receptor locus. 5 On the other hand, the effects of genotype on LDL cholesterol were additive to the influence of early undernutrition. 6 Impaired fetal and infant growth is associated not only with increased hypertension incidence, 7 but also with insulin resistance, high plasma triglycerides, elevated LDL cholesterol, and decreased HDL cholesterol. 8 -10 Nutrition in pregnancy, lactation, or during the weaning period also programs future development of lipid metabolism in the rat. 11, 12 Altered fetal nutrition can also cause hypertension in offspring of normotensive mothers 13, 14 and impair glucose tolerance in the adult rat. 15 In spontaneously hypertensive rats (SHR), abnormal lipid metabolism was detected even at birth. 16 Changes in both circulating and membrane lipids were observed in SHR prior to hypertension development. [17] [18] [19] Similarly, alterations of lipid metabolism in essential hypertension can be traced to early childhood 20, 21 and are also present in normotensive subjects with a positive family history of hypertension. 22, 23 Finally, the dietary influence on lipid metabolism and blood pressure (BP) has been well documented in hypertensive rats and humans. 24 -26 The alterations of membrane cholesterol or phospholipid content, phospholipid distribution, molecular species pattern of particular phospholipid classes, and degree of fatty acid saturation were reported in both human [27] [28] [29] and experimental hypertension. 19, 30, 31 These changes in membrane lipid composition may modulate membrane function in a longterm manner, contributing to abnormal chronic BP regulation.
MEMBRANE MICROVISCOSITY
Membrane microviscosity (reciprocal value of membrane fluidity) is one of the biophysical characteristics of the cell membrane, the properties of which are modified in hypertension. 32 Alterations in membrane microviscosity usually reflect changes in its lipid composition 1 or phospholipid distribution, 33 which are often dependent on nutrition and metabolism. Membrane microviscosity can also be influenced by redox status, phosphorylation state of membrane components, local pH, calcium concentration, or cytoskeleton proteins.
Fluorescence polarization anisotropy of diphenylhexatriene (DPH) derivatives and electron spin resonance (using spin-labeled fatty acids) provide the information about particular aspects of membrane microviscosity. Rotational mobility and lateral diffusion can be investigated in selected cell membrane domains. 34 -37 Thus microviscosity alterations occurring in the hydrophobic membrane lipid core (estimated by diphenylhexatriene [DPH]) can be distinguished from those concerning the other parts of the membrane, eg, outer leaflet (probed by trimethylaminodiphenylhexatriene [TMA-DPH]). Nevertheless, the data obtained by different probes should be interpreted with caution because the localization of certain probes is still unclear or changes during cell activation or prolonged incubation. 38 For example, transbilayer TMA-DPH movement, occurring with a half-life of 60 to 90 min in unstimulated platelets, results in progressive labeling of the inner membrane leaflet and intracellular compartments. 39, 40 Under physiologic conditions membrane microviscosity increases with rising membrane cholesterol content, whereas the opposite effects are exerted by changes in the degree of unsaturation of phospholipid acyl chains. The amount and nature of membrane phospholipids are also important determinants of its microviscosity. A positive correlation between DPH anisotropy and cholesterol-to-phospholipid (C:PL) molar ratio was indeed reported in human platelets, 41 in which the importance of particular membrane phospholipid classes was documented. 42 The in vitro enrichment of membranes with triglycerides or cholesterol can selectively modify microviscosity in distinct membrane domains. 37 Although triglycerides form a minor part of membrane lipids, their amount can be elevated under certain circumstances, such as cell activation. 43 Besides the cell's capacity to synthesize or metabolize lipids, membrane composition can be influenced by an intensive exchange between plasma and membrane lipids. However, membrane microviscosity is influenced more by plasma triglycerides than by plasma cholesterol. 44 An inverse relationship between plasma triglycerides and DPH anisotropy was observed in human platelets and erythrocytes. 41, [45] [46] [47] Similarly, the C:PL molar ratio did not correlate with plasma cholesterol but was inversely related to plasma triglycerides. 48 Using platelets of Prague hereditary hypertriglyceridemic (HTG) rats 49 we described a positive association of plasma triglycerides with TMA-DPH anisotropy (outer membrane leaflet) and a negative association with DPH anisotropy (lipid core) ( Figure  1 ). The same tendency was also seen in platelets of control Wistar rats, in which the slopes of the respective regression lines were always steeper than the slopes found in HTG platelets. The slopes of triglyceride dependence were also reduced in HTG rats when erythrocyte Ca 2ϩ influx 50 or thrombin-induced platelet aggregation were investigated. 51 Thus functional and biophysical membrane parameters are similarly associated with plasma triglycerides. It would be interesting to identify the compensatory mechanism(s) counterregulating the influence of chronically elevated plasma triglycerides that are responsible for the diminished slope of triglyceride dependence in HTG rats.
Our findings on triglyceride dependence of DPH and TMA-DPH anisotropies in intact rat platelets are in good agreement with the results obtained in phosphatidylcholine vesicles in which triglyceride enrichment also decreased DPH anisotropy and increased TMA-DPH anisotropy. 37 The influence of plasma triglycerides on membrane microviscosity appears to depend on the membrane lipid composition, as indicated by their inverse correlations with TMA-DPH anisotropy in human erythrocytes, 47 lymphocytes, 52 and platelets. 42 A great effort was given to the search for widespread structural alterations of cell membranes in hypertension because altered membrane microviscosity could affect various membrane functions such as membrane permeability, transport systems, receptor coupling, or enzyme activities. This would explain the simultaneous occurrence of multiple functional abnormalities in hypertensive patients or animals as pleiotropic manifestations of a generalized membrane defect.
Early studies indicated increased membrane microviscosity in various cells of spontaneously hypertensive rats [53] [54] [55] [56] and essential hypertensive patients. [57] [58] [59] Such changes were absent in rats and patients with secondary hypertension. 55, 57 Not only rotational mobility but also lateral diffusion were reduced in membranes of genetically hypertensive animals. 55, 60 These membrane changes were already observed in young SHR or stroke-prone SHR (SHRSP) aged 3 to 6 weeks. 30, 54, 60 Membrane microviscosity was more altered in male than in female SHR that were less hypertensive. 61 In SHR erythrocytes, the changes of membrane fluidity were almost independent of age, 53,56,62 whereas age-dependent increases in membrane microviscosity were demonstrated in platelets of male SHR.
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Our later studies revealed decreased microviscosity of the membrane lipid core in platelets and erythrocytes of Lyon hypertensive rats 64 and salt-sensitive Dahl rats. 65 Decreased lipid core microviscosity was also found in membranes isolated from aorta, 66 intestinal brush border, 67, 68 and liver of SHR. 31 Moreover, platelets of essential hypertensive patients are characterized by unaltered DPH anisotropy but decreased TMA-DPH anisotropy that correlates negatively with BP. 69 Inverse correlation between BP and DPH anisotropy was also demonstrated in erythrocyte ghosts of three independent strains with genetic hypertension, ie, in Lyon, Dahl, and Sabra rats. 65 Available genetic studies 70, 71 failed to reveal a cosegregation of increased membrane microviscosity with BP in SHRSP ϫ WKY or SHR ϫ WKY F 2 hybrids. This casts some doubt on the concept that a generalized decrease in membrane fluidity would play a major role in the pathogenesis of genetic hypertension. However, none of these cosegregation studies paid attention to membrane or plasma lipids although microviscosity of the membrane lipid bilayer was studied in detail. This aspect should be addressed in future studies because alterations of membrane microviscosity in hypertensive patients 41, 72 and various hypertensive models 49, 64 seem to be based upon their abnormal lipid metabolism.
MONOVALENT ION TRANSPORT IN ERYTHROCYTES
Ion transport defects were disclosed in various cells, including erythrocytes of essentially hypertensive patients. Because erythrocytes have no endogenous synthesis of lipids, their membrane lipid composition better reflects plasma lipids than that of endothelial or vascular cells. However, exogenous cholesterol also regulates endogenous cholesterol synthesis in the latter cell types. Ion transport alterations are often associated with abnormal lipid metabolism, as can be illustrated for the Na ϩ -Li ϩ countertransport system. Its kinetic properties are dependent on membrane lipid composition [73] [74] [75] and its increased activity in erythrocytes of hyperlipidemic or hypertensive patients 76 -78 can be reduced by lipid-lowering therapy. 74 Dietary modification of erythrocyte membrane lipid composition affects various Na ϩ transport systems, including Na ϩ -K ϩ pump, Na
Ϫ cotransport, Na ϩ leak, and partially also Na ϩ -Li ϩ countertransport. 79, 80 Na ϩ -Li ϩ countertransport activity is inversely related to the membrane content of polyunsaturated fatty acids 28, 73, 81 and also depends on the amount and distribution of cholesterol 28, 81, 82 as well as on the content of particular classes and molecular species of phospholipids in erythrocyte membranes. 75, 81, 83, 84 Thus, modified composition of the phosphatidylethanolamine molecular species is responsible for kinetic changes of the Na ϩ -K ϩ pump in human hyperlipidemia. 85 Moreover, membrane incorporation of exogenous short-chain diacyl phosphatidylcholines decreased the Na ϩ -K ϩ pump activity in human erythrocytes. 86 Similarly, in-vitro-induced changes of phosphatidylcholine molecular species in erythrocyte membranes influenced furosemide-sensitive Rb ϩ uptake mediated by the Na ϩ -K ϩ -2Cl Ϫ cotransport system. 87 Linoleic acid supplementation, which modified membrane content of particular fatty acids, decreased ouabain-resistant Na ϩ efflux in human leukocytes.
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The cholesterol-to-phospholipid molar ratio is an important determinant of membrane microviscosity, 89 the increase of which is associated with altered kinetics of the Na ϩ -Li ϩ countertransport system. 90, 91 Both the membrane C:PL molar ratio 41, 48 and DPH aniso- The influence of plasma triglycerides on the ion transport systems mentioned is usually more pronounced than that of plasma cholesterol; HDL cholesterol has a strong inverse relationship to the activity of ion transport systems (Table 1) .
In contrast to humans, there is only scarce information on the relationship between erythrocyte ion transport and abnormal lipid metabolism in the rat, although multiple ion transport alterations were disclosed in erythrocytes of SHR 96 and other rat strains with genetic hypertension. [97] [98] [99] There are two independently selected inbred rat strains with genetic hypertension accompanied by abnormal lipid metabolism: Lyon hypertensive (LH) rats and Prague hereditary hypertriglyceridemic (HTG) rats. LH rats were originally selected from SpragueDawley rats for BP elevation 100 and high BP was accompanied by increased plasma cholesterol and triglycerides. 101 In contrast, HTG rats, which were selected from Wistar rats for high plasma triglycerides, 102 were also found to be hypertensive. 103 Our recent study 104 compared Na ϩ transport in erythrocytes of the two rat models of genetic hypertension accompanied by dyslipidemia. Both HTG and LH rats had elevated plasma triglycerides, whereas plasma total cholesterol was increased in LH rats but decreased in HTG animals. The two strains resembled each other in moderate elevations of erythrocyte Na ϩ content and leak but they differed in bumetanidesensitive Na ϩ net uptake (mediated by the Na ϩ -K ϩ -2Cl Ϫ cotransport system), which was augmented in HTG but reduced in LH rats. Two important associations were disclosed in both hypertensive strains. Plasma triglycerides correlated positively with erythrocyte Na ϩ content and BP was positively related to Na ϩ leak. Both associations were confirmed by the significant cosegregation of these parameters in HTG ϫ Lewis F 2 hybrids. 104 The cosegregation of BP with Na ϩ leak is in accordance with the importance of Na ϩ leak in genetic hypertension. 105, 106 Similar cosegregation was demonstrated in Prague recombinant inbred strains (derived from SHR ϫ Brown Norway F 2 hybrids). 107 In Dahl rats, Na ϩ leak was enhanced, especially in erythrocytes of young salt-sensitive animals with severe salt hypertension. 99 The importance of high plasma triglycerides in the control of Na ϩ influx is further supported by positive correlations of plasma triglycerides with Na ϩ leak in essential hypertension 92, 95 and in HTG rats. 104 There is an important question about which mechanisms might be responsible for the association of elevated plasma triglycerides with abnormal ion transport. The interrelationships mentioned between plasma triglycerides, membrane C:PL molar ratio, fluorescence anisotropies, and the activity of various Na ϩ transport systems suggest that triglyceride-dependent ion transport alterations might be due to altered membrane microviscosity. Our data from Lyon 64 and HTG rats 49 indicate that at least triglyceride-dependent cell Ca 2ϩ handling is closely related to membrane microviscosity.
The influence of membrane cholesterol content on particular ion transport systems has been extensively studied in hypercholesterolemic patients and after in vitro modulation of membrane cholesterol content. A classical example is the influence of membrane cholesterol on Na ϩ -K ϩ pump activity. Progressive in vitro membrane cholesterol depletion increased maximal transport rate (V max ) of the Na ϩ -K ϩ pump and reduced its affinity for internal sodium. 108, 109 Similarly, a moderate reduction of membrane cholesterol content in erythrocytes of pravastatin-treated patients was accompanied by increased ouabain-sensitive Na ϩ efflux and decreased erythrocyte Na ϩ content. 110 The in vitro membrane cholesterol enrichment was associated with reduced activity of the Na ϩ -K ϩ pump (lowered V max and increased affinity for internal sodium), Na ϩ -Li ϩ countertransport, Na
Ϫ cotransport, and with lower passive permeability of erythrocyte membranes for Li ϩ , Na ϩ , and K ϩ . 111, 112 Nevertheless, it should be kept in mind that membrane cholesterol content can often reach nonphysiologically high values after in vitro membrane cholesterol enrichment.
The Na
Ϫ cotransport activity is also inversely related to membrane cholesterol content. The negative correlation between Na ϩ -K ϩ cotransport activity and membrane cholesterol content in human erythrocytes 81, 113 is in accordance with the reduced Na ϩ -K ϩ cotransport activity seen after in vitro cholesterol enrichment of the erythrocyte membrane.
111,114 A possible variance in membrane cholesterol content (due to a different cholesterol metabolism) also offers a plausible explanation for the enhanced cotransport activity in HTG rats with low plasma cholesterol and for the reduced activity in LH rats characterized by high plasma cholesterol.
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CELL CALCIUM HANDLING
Cytosolic free Ca 2ϩ concentration ([Ca 2ϩ ] i ) is elevated in vascular smooth muscle cells (VSMC) [115] [116] [117] and in various blood cells of SHR. 118 -120 The same is true for several other rat strains with genetic hypertension [121] [122] [123] but not for salt-sensitive Dahl or Sabra rats. 124, 125 Increased [Ca 2ϩ ] i was also demonstrated in plate- 144 The spontaneous and norepinephrine-induced oscillatory contractions of vascular smooth muscle from SHR or SHRSP, which are related to altered K ϩ efflux dependent on higher Ca 2ϩ entry sensitive to Ca 2ϩ channel blockers, 145, 146 also cosegregated with BP of the respective F 2 hybrids. 146, 147 In addition, increased Ca 2ϩ entry through L-type channels is also responsible for augmented contraction of SHRSP arteries due to membrane depolarization after Na ϩ -K ϩ pump inhibition. 148 This abnormality is already present in the prehypertensive stage 149 and cosegregated with BP of SHRSP ϫ WKY F 2 hybrids. 150 On the contrary, cosegregation studies performed with platelets did not reveal a significant association between BP and [Ca 2ϩ ] i , in SHR ϫ Donryu F 2 hybrids 151 or LH ϫ Lewis F 2 hybrids (Zicha et al, unpublished data). Nevertheless, using a backcross population derived from Lyon hypertensive and normotensive rats, 152 a quantitative trait locus was identified on rat chromosome 2, which had no effect on basal BP or its decrease elicited by ganglionic or AT 1 receptor blockade, but was closely related to BP response induced by L-type Ca 2ϩ channel blockade. Genetic analysis further demonstrated an important association of BP with plasma lipids in Lyon hypertensive and HTG rats. Studies in Lyon rat strains 153, 154 revealed highly significant cosegregations of BP not only with total cholesterol levels (both with LDL and HDL fractions) but also with plasma triglycerides and phospholipids. A strong cosegregation of BP with plasma triglycerides was observed in HTG ϫ Lewis F 2 hybrids, but we failed to find any significant relationship between BP and plasma cholesterol. 155, 156 Low-density lipoproteins cause a dose-dependent [Ca 2ϩ ] i increase in cultured rat VSMC, mediated by substantially enhanced Ca 2ϩ influx and by mobilization of Ca 2ϩ stores. 157 It is important to mention that Ca 2ϩ influx in cultured rat VSMC is augmented not only by LDL but also by HDL 3 , the extent of cell signaling elicited by both lipoprotein fractions being almost identical. 158 This could explain a cosegregation of BP with these two lipoprotein fractions in Lyon F 2 hybrids. 153 Cell Ca 2ϩ handling is also associated with plasma or membrane lipids in humans. 159 Platelet [Ca 2ϩ ] i correlates positively with membrane C:PL molar ratio 160 and with plasma cholesterol levels. 127, 161 It also tended to increase with plasma LDL and to decrease with HDL level. 127, 162 Figure 2 shows the relationships of platelet [Ca 2ϩ ] i with plasma triglycerides and particular cholesterol fractions in normotensive and hypertensive subjects. 162 The contrasting relationships of platelet [Ca 2ϩ ] i to particular cholesterol fractions can be explained by the fact that LDL increases Ca 2ϩ influx in human platelets and that this effect is prevented by HDL 3 . 163 Reduction of plasma total cholesterol and LDL cholesterol levels by the inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase was indeed accompanied by lowering of platelet [Ca 2ϩ ] i .
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A positive correlation between plasma triglycerides and platelet [Ca 2ϩ ] i was found not only in hypertensive but also in normotensive subjects. 127, 162 Plasma triglycerides seem to influence cell Ca 2ϩ handling because their lowering by dietary n-3 fatty acids also reduced platelet [Ca 2ϩ ] i . 164 Plasma triglycerides may modulate membrane properties either directly via their incorporation into the phospholipid bilayer 165 or indirectly via the associated alterations in membrane lipid composition 41 ] i with TMA-DPH and DPH anisotropies in human platelets. 162 Our experiments in Lyon 64 and HTG rats 49 revealed somewhat different relationships between membrane microviscosity and platelet [Ca 2ϩ ] i (Fig. 3) . Platelet [Ca 2ϩ ] i correlated positively with TMA-DPH anisotropy but negatively with DPH anisotropy. The positive association of platelet [Ca 2ϩ ] i with TMA-DPH anisotropy in the rat is, however, at variance with the inverse relationship observed in humans. 69, 162 On the other hand, using Lyon rat strains and especially HTG rats, we confirmed the influence of plasma triglycerides on cell Ca 2ϩ handling. 50, 123 Not only Ca 2ϩ influx into erythrocytes but also thrombin-induced Mn 2ϩ entry into platelets, another index of Ca 2ϩ influx, are related to plasma triglycerides (Fig. 4) . The analysis of platelet Ca 2ϩ handling in Lyon rats 123 indicates that both Ca 2ϩ influx and thrombin-induced Mn 2ϩ entry were also associated with plasma triglycerides. The slopes of the respective regression lines were always steeper in control normolipidemic rats than in hypertensive dyslipidemic animals (HTG or LH rats), suggesting a downregulation in response to chronically elevated plasma triglycerides. Such desensitization indicates that the in vivo influence of chronically elevated plasma triglycerides could be important enough to be counterregulated, to maintain structural and functional properties of the cell membrane within the physiologic range.
INTRACELLULAR pH REGULATION
Intracellular pH (pH i ) is regulated by the concerted action of the Na ϩ /H ϩ exchanger and bicarbonate transporting systems, including electroneutral Na ϩ dependent (cell-alkalinizing) and Na ϩ -independent (cell-acidifying) HCO 3 Ϫ /Cl Ϫ exchangers. 167, 168 The activity of these regulatory systems is highly dependent on prevailing pH i . At present there is an intensive search for possible kinetic abnormalities of these exchangers to explain the pH i changes observed in hypertensive humans and animals.
The acid-base status seems to be altered in both hypertensive patients and genetically hypertensive rats. Increased renal acid excretion suggests the perturbation of acid-base status that might result from increased acid production. This metabolic abnormality would be compatible with decreased pH i and an enhanced Na ϩ /H ϩ exchanger. 169 A mild metabolic acidosis was indeed described in SHR 170 and increased acid production was reported in salt-sensitive Dahl rats. 171 It is, however, difficult to say whether basal pH i in hypertensive humans is altered or not. 172 Resting pH i was found to be unchanged in resistance vessels of essentially hypertensive patients in which neither the Na ϩ /H ϩ exchanger nor the anion exchanger were hyperactive compared with normotensive controls. 173 On the other hand, decreased pH i was described in erythrocytes and lymphocytes of hypertensive humans, 132, 174, 175 whereas increased pH i was often observed in leukocytes and platelets of these patients. 176 -178 The activity of the Na 
/Cl
Ϫ exchangers is augmented in erythrocytes of patients with essential hypertension.
181,182 V max of the Na ϩ /H ϩ exchanger seems to be generally increased in essential hypertension, but its affinity for external Na ϩ or pH i is unchanged. 172 The setpoint for activation of the Na ϩ /H ϩ exchanger is more alkaline in platelets of essentially hypertensive patients 183, 184 and this pH i setpoint is dependent on plasma HDL cholesterol level. 185 It would therefore be interesting to know how abnormal lipid metabolism can influence the Na The in vitro membrane cholesterol depletion activated Na ϩ /H ϩ exchange, whereas membrane cholesterol enrichment reduced its activity in lymphoblasts. 186 Na ϩ /H ϩ exchanger activity is also influenced by membrane cholesterol content in human platelets. 187 The preincubation of human platelets with HDL stimulated Na ϩ /H ϩ exchange, whereas LDL had the opposite effect. 188, 189 Similarly, intracellular alkalinization and acidification were induced by HDL and LDL in human vascular endothelial cells. 190 There is little information on the relationships between abnormal lipid metabolism and pH i regulation in humans. The amiloride-sensitive response of platelet volume to cytoplasmic acidification (taken as an estimate of Na ϩ /H ϩ exchange) was reduced in lovastatin-treated hypertensive patients. 191 Reduced V max of the Na ϩ /H ϩ exchanger was found in erythrocytes of essential hypertensive patients chronically treated with lisinopril, which also lowered their plasma total and LDL cholesterol levels. 192 In leukocytes of hypertensive patients, resting pH i correlated negatively with plasma cholesterol, whereas Na ϩ -dependent H ϩ efflux appeared to be positively related with plasma triglycerides. 193 Plasma total cholesterol and LDL cholesterol correlated positively with Na ϩ /H ϩ exchanger activity in leukocytes of normotensive humans. 194 Furthermore, multiple regression analysis revealed a positive association of plasma cholesterol with V max of the Na ϩ /H ϩ exchanger in lymphocytes of normotensive subjects. 52 Finally, some data indicate the dependence of the Na ϩ /H ϩ exchanger properties on membrane microviscosity. A negative association of TMA-DPH anisotropy with the affinity of the Na ϩ /H ϩ exchanger for external Na ϩ was described in human leukocytes, 52 whereas resting platelet pH i varied inversely with TMA-DPH but not with DPH anisotropy. 195 Alterations of intracellular pH regulation are also present in hypertensive animals. Decreased pH i was found in lymphocytes of SHR, 196, 197 Mü nster hypertensive rats, 198 and Dahl salt-sensitive rats, 171 as well as in erythrocytes of rats with experimental hypertension. 174 Moreover, lower pH i was seen in platelets of salt-sensitive Sabra and Dahl rats 199, 200 but not in those of rats with spontaneous hypertension. 50, 123, 201 On the other hand, increased pH i was often detected in VSMC of SHR [202] [203] [204] [205] although unchanged 206 or even decreased pH i values 207 were also described. Nevertheless, it should be noted that pH i in resistance arteries of SHR was increased only in young, 5-week-old, but not in adult, 12-week-old, animals 203 ; increased pH i in resistance arteries of adult SHR was only observed in absence of bicarbonate 205 ; and higher pH i seen initially in cultured VSMC from SHR disappeared after several passages. 204 In contrast to the scarce information about the activity of HCO 3 Ϫ /Cl Ϫ exchangers in genetic hypertension, 197, 208 Na ϩ /H ϩ exchanger activity is increased in various blood cells 179, 209, 210 and cultured VSMC of SHR. 202, 207, 211 The enhanced rate of Na ϩ /H ϩ exchange in SHR is ascribed to increased V max , whereas further kinetic alterations of the Na ϩ /H ϩ exchanger are still uncertain. 204, 206, 211, 212 At present, it is difficult to evaluate the role of enhanced Na ϩ /H ϩ exchange in the pathogenesis of hypertension. In SHR ϫ WKY F 2 hybrids BP did not cosegregate with Na ϩ /H ϩ exchange in erythrocytes, 213 but was associated with impaired dopaminergic control of Na ϩ /H ϩ exchange in renal brush border membranes. 214 As far as human hypertension is concerned, genetic linkage analysis excluded Na ϩ /H ϩ antiporter as a candidate gene for essential hypertension. 215 Similarly to humans, pH i regulation in the rat is also affected by lipid abnormalities. A biphasic pattern of pH i response to LDL (transient acidification followed by prolonged alkalinization) was observed in cultured rat aortic fibroblasts and VSMC. 216, 217 The cellular signaling elicited by LDL is enhanced in cultured VSMC of SHR. 158 In contrast to human platelets, Na ϩ /H ϩ exchanger activity in rat VSMC is stimulated not only by LDL but also by HDL 3 , resulting in a similar pH i rise in both cases. 158 Thus, in rat VSMC, both lipoprotein fractions enhance Ca 2ϩ influx and augment Na ϩ /H ϩ exchanger activity. The regulation of pH i in platelets of Dahl rats is also dependent on plasma lipids. 200 Figure 5 shows that plasma cholesterol level correlated positively with basal pH i values but negatively with thrombin-induced pH i changes that reflect Na ϩ /H ϩ exchanger activation. These relationships might be mediated by membrane microviscosity because there was an inverse correlation between plasma cholesterol and DPH anisotropy, which was positively associated with thrombin-induced pH i rise ( Figure 5 ). Further detailed analysis of the interrelationships between plasma or membrane lipids, membrane microviscosity, and intracellular pH regulation would therefore be highly desirable not only in hypertensive or dyslipidemic animals and patients but also in in vitro cell systems.
CONCLUSIONS
It is evident that the changes in membrane lipid composition may modulate membrane function in a longterm manner, leading to abnormal chronic BP regulation. Future studies of functional membrane properties in hypertension should therefore consider the detailed composition of membrane lipids and the microviscosity in particular membrane domains. 
